The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders.
You might also be interested in reading Tom Lee Calls for 100x Ethereum ‘Supercycle’ Like Bitcoin as BitMine Adds More ETH.